These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 1300330

  • 1. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
    Coen G, Mazzaferro S, Ballanti P, Bonucci E.
    J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
    Bervoets AR, Spasovski GB, Behets GJ, Dams G, Polenakovic MH, Zafirovska K, Van Hoof VO, De Broe ME, D'Haese PC.
    Am J Kidney Dis; 2003 May; 41(5):997-1007. PubMed ID: 12722034
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation among markers of renal osteodystrophy in pediatric hemodialysis patients.
    Piscitelli J, Cabansag MR, Silverstein DM.
    J Pediatr Endocrinol Metab; 1999 May; 12(6):879-86. PubMed ID: 10614547
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Determination of bone mineral content and correlations with calciotropic hormones in periodic hemodialysis patients].
    Anelli F, De Maio P, Girardi V, Papagni S, Rossi G, Cantatore FP, Carrozzo M.
    Minerva Urol Nefrol; 1992 May; 44(4):265-73. PubMed ID: 1299008
    [Abstract] [Full Text] [Related]

  • 13. News on biomarkers in CKD-MBD.
    Mazzaferro S, Tartaglione L, Rotondi S, Bover J, Goldsmith D, Pasquali M.
    Semin Nephrol; 2014 Nov; 34(6):598-611. PubMed ID: 25498379
    [Abstract] [Full Text] [Related]

  • 14. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
    Avila-Díaz M, Matos M, García-López E, Prado MD, Castro-Vázquez F, Ventura MD, González E, Amato D, Paniagua R.
    Perit Dial Int; 2006 Nov; 26(1):78-84. PubMed ID: 16538879
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study.
    De Paola L, Coppolino G, Bolignano D, Buemi M, Lombardi L.
    Ther Apher Dial; 2010 Dec; 14(6):566-71. PubMed ID: 21118364
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
    Di Landro D, Zanatta GP, Simioni N, Pinzani A, Zotti D, Perin N, Bertoli M, Naso A, Ruffatti A, Gasparotto ML.
    Minerva Med; 1985 Mar 10; 76(9-10):419-23. PubMed ID: 3982699
    [No Abstract] [Full Text] [Related]

  • 20. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
    Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K.
    Kidney Int; 1999 Sep 10; 56(3):1084-93. PubMed ID: 10469378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.